Company & Sponsor Intelligence
University of British Columbia
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting1
Completed3
Countries1
Therapeutic footprint
adhddepressionparkinsonsstroke
Indexed studies
NCT06915987Parkinson Disease and Exercise Snacks
parkinsons · CanadaNA
parkinsons · CanadaNA
NCT00434928Dietary Intake and Nutrient Status of Children With ADHD
adhd · CanadaCOMPLETED
adhd · CanadaCOMPLETED
NCT02167048Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Individuals With ADHD
adhd · CanadaPHASE1, PHASE2
adhd · CanadaPHASE1, PHASE2
NCT06573125A Feasibility and Preliminary Efficacy Study of an App-Based Physical Activity Intervention (MoodMover) for Depression
depression · NA
depression · NA
NCT02654951Reaching in Stroke
stroke · CanadaNA
stroke · CanadaNA
NCT01915368Determining Optimal Post-Stroke Exercise (DOSE)
stroke · CanadaNA
stroke · CanadaNA
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →